These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Semicarbazide-sensitive amine oxidase in transgenic mice with diabetes. Gokturk C; Nordquist J; Sugimoto H; Forsberg-Nilsson K; Nilsson J; Oreland L Biochem Biophys Res Commun; 2004 Dec; 325(3):1013-20. PubMed ID: 15541390 [TBL] [Abstract][Full Text] [Related]
4. Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation. Boomsma F; Hut H; Bagghoe U; van der Houwen A; van den Meiracker A Med Sci Monit; 2005 Apr; 11(4):RA122-6. PubMed ID: 15795708 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681 [TBL] [Abstract][Full Text] [Related]
6. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases. Solé M; Unzeta M Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380 [TBL] [Abstract][Full Text] [Related]
7. SSAO/VAP-1 protein expression during mouse embryonic development. Valente T; Solé M; Unzeta M Dev Dyn; 2008 Sep; 237(9):2585-93. PubMed ID: 18729210 [TBL] [Abstract][Full Text] [Related]
8. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Abella A; García-Vicente S; Viguerie N; Ros-Baró A; Camps M; Palacín M; Zorzano A; Marti L Diabetologia; 2004 Mar; 47(3):429-438. PubMed ID: 14968297 [TBL] [Abstract][Full Text] [Related]
9. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes. Bour S; Daviaud D; Gres S; Lefort C; Prévot D; Zorzano A; Wabitsch M; Saulnier-Blache JS; Valet P; Carpéné C Biochimie; 2007 Aug; 89(8):916-25. PubMed ID: 17400359 [TBL] [Abstract][Full Text] [Related]
10. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress. Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025 [TBL] [Abstract][Full Text] [Related]
11. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke. Hernandez-Guillamon M; Solé M; Delgado P; García-Bonilla L; Giralt D; Boada C; Penalba A; García S; Flores A; Ribó M; Alvarez-Sabin J; Ortega-Aznar A; Unzeta M; Montaner J Cerebrovasc Dis; 2012; 33(1):55-63. PubMed ID: 22133888 [TBL] [Abstract][Full Text] [Related]
12. A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme. Bonaiuto E; Lunelli M; Scarpa M; Vettor R; Milan G; Di Paolo ML Biochimie; 2010 Jul; 92(7):858-68. PubMed ID: 20298739 [TBL] [Abstract][Full Text] [Related]
13. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia. Sun P; Solé M; Unzeta M Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888 [TBL] [Abstract][Full Text] [Related]
14. VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients. Koc-Zorawska E; Malyszko J; Malyszko JS; Mysliwiec M Kidney Blood Press Res; 2012; 36(1):242-7. PubMed ID: 23154672 [TBL] [Abstract][Full Text] [Related]
15. Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity. Jargaud V; Bour S; Tercé F; Collet X; Valet P; Bouloumié A; Guillemot JC; Mauriège P; Jalkanen S; Stolen C; Salmi M; Smith DJ; Carpéné C J Physiol Biochem; 2021 Feb; 77(1):141-154. PubMed ID: 32712883 [TBL] [Abstract][Full Text] [Related]
16. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects. Li HY; Lin MS; Wei JN; Hung CS; Chiang FT; Lin CH; Hsu HC; Su CY; Wu MY; Smith DJ; Vainio J; Chen MF; Chuang LM Clin Chim Acta; 2009 May; 403(1-2):97-101. PubMed ID: 19361461 [TBL] [Abstract][Full Text] [Related]
17. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623 [TBL] [Abstract][Full Text] [Related]
18. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases. Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216 [TBL] [Abstract][Full Text] [Related]
19. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking. Yraola F; García-Vicente S; Fernandez-Recio J; Albericio F; Zorzano A; Marti L; Royo M J Med Chem; 2006 Oct; 49(21):6197-208. PubMed ID: 17034126 [TBL] [Abstract][Full Text] [Related]
20. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation. Yu PH; Lu LX; Fan H; Kazachkov M; Jiang ZJ; Jalkanen S; Stolen C Am J Pathol; 2006 Mar; 168(3):718-26. PubMed ID: 16507887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]